Cargando…
Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy
Toll-like receptor 3 (TLR3), as an important pattern recognition receptor (PRR), dominates the innate and adaptive immunity regulating many acute and chronic inflammatory diseases. Atherosclerosis is proved as an inflammatory disease, and inflammatory events involved in the entire process of initiat...
Autores principales: | Cen, Xiaohong, Wang, Baoqu, Liang, Yuqing, Chen, Yanlin, Xiao, Yu, Du, Shaohua, Nandakumar, Kutty Selva, Yin, Hang, Liu, Shuwen, Cheng, Kui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513496/ https://www.ncbi.nlm.nih.gov/pubmed/36176917 http://dx.doi.org/10.1016/j.apsb.2022.06.001 |
Ejemplares similares
-
TLR1/2 Specific Small‐Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes
por: Cen, Xiaohong, et al.
Publicado: (2019) -
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
por: Cen, Xiaohong, et al.
Publicado: (2018) -
SMU Open-Source Platform for Synchronized Measurements
por: Guarnieri Calò Carducci, Carlo, et al.
Publicado: (2022) -
Potential treatment methods targeting 2019-nCoV infection
por: Zheng, Lu, et al.
Publicado: (2020) -
A highly selective and sensitive chemiluminescent probe for leucine aminopeptidase detection in vitro, in vivo and in human liver cancer tissue
por: Wang, Baoqu, et al.
Publicado: (2022)